| History |
| Coital practices |
| Medical history (e.g., genetic disorders, endocrine disorders, history of pelvic inflammatory disease) |
| Medications (e.g., hormone therapy) |
| Menstrual history |
| Potential sexually transmitted disease exposure, symptoms of genital inflammation (e.g., vaginal discharge, dysuria, abdominal pain, fever) |
| Previous fertility |
| Substance use, including caffeine |
| Surgical history (previous genitourinary surgery) |
| Toxin exposure |
| Physical examination |
| Breast formation |
| Galactorrhea |
| Genitalia (e.g., patency, development, masses, tenderness, discharge) |
| Signs of hyperandrogenism (e.g., hirsutism, acne, clitoromegaly) |
| Laboratory evaluation/specialized tests |
| To document ovulation: measurement of mid-luteal progesterone level, urinary luteinizing hormone using home prediction kit, and basal body temperature charting |
| To determine etiology if ovulatory dysfunction suspected: measurement of FSH, prolactin, thyroid-stimulating hormone, 17α-hydroxyprogesterone (if hyperandrogenism suspected), testosterone (if hyperandrogenism suspected) |
| To assess ovarian reserve (women older than 35 years): measurement of FSH and estradiol levels on day 3 of the menstrual cycle, clomiphene citrate (Clomid) challenge test, or transvaginal ultrasonography for antral follicle count |
| To assess tubes, uterus, and pelvis: transvaginal ultrasonography, hysterosalpingography if tubal dysfunction suspected or evaluation otherwise unrevealing, hysteroscopy if results of hysterosalpingography suggest intrauterine abnormality, laparoscopy if results of hysterosalpingography abnormal or evaluation otherwise unrevealing |